I think there is lots of upside IF Optiscan can get to the point...

I think there is lots of upside IF Optiscan can get to the point that Zeiss is selling their Neuroligical microscopy solution.
Optiscan has to engineer the requested enhancements while living hand to mouth for at least a year until Zeiss Meditec complete the required trials etc. Progress payments and sales of CellLIVE could be enough in a best case scenario. Let's hope that a lot of the work requested has already been done for CellLIVE.
But there is an awful lot of risk that it won't go smoothly - as exemplified by the R&D refund - and then more capital will be required. If that happens Optiscan will surelynot be able to raise capital at 5c again. So what is the right price for Optiscan at the moment? I have no idea. I'm guessing that it might settle at about 3.5c for a while